Murad Hussain

Murad is a partner in the Healthcare, Litigation & Dispute Resolution, Government Investigations, and International Trade practices. He represents healthcare providers, life sciences companies, multinational businesses, and others in government investigations, False Claims Act (“FCA”) litigation, white collar criminal matters, regulatory enforcement actions, and complex disputes. He also serves as AGG’s chair of Foreign Agents Registration Act (“FARA”) Compliance. Murad combines seasoned trial and investigations experience with business-focused counsel to protect and advance clients’ operations, reputations, and long-term objectives.

Clients turn to Murad when facing high-stakes investigations and audits by the U.S. Department of Justice (“DOJ”), the U.S. Department of Health and Human Services Office of Inspector General (“HHS-OIG”), the Centers for Medicare and Medicaid Services (“CMS”), state attorneys general, and other federal and state regulators. His practice is distinguished by two complementary areas: defending healthcare providers and life sciences companies in government investigations, FCA qui tam suits, and Medicare disputes, and representing domestic and international clients in cross-border enforcement, compliance, and litigation matters. Murad regularly counsels clients on matters involving alleged criminal and civil healthcare fraud, the Anti-Kickback Statute, export controls, customs and tariff laws, and FARA. Across his practice, Murad has successfully defended his clients in federal criminal jury trials, won dismissals of FCA lawsuits, negotiated declinations and other favorable resolutions of complex government investigations and litigation, and brought affirmative litigation against the government to vindicate his clients’ rights.

Murad is a committed advocate for healthcare providers nationwide, including individual physicians, medical practices, hospital systems, life sciences companies, and executives. He has deep experience defending practitioners in specialties receiving heightened scrutiny by CMS, HHS-OIG, and DOJ, including outpatient interventional cardiology and interventional radiology, Mohs surgery, wound care, and ophthalmology. Murad also helps clients strengthen their compliance programs by advising on emerging enforcement trends, including the government’s growing use of artificial intelligence, data analytics, and statistical modeling to target billing and reimbursement patterns.

Murad’s cross-border enforcement practice complements his healthcare work, reflecting the increasingly global and multidisciplinary nature of government investigations. As AGG’s chair of FARA Compliance, he advises multinational companies, investors, foreign-funded U.S. entities, and other cross-border operators on evolving U.S. regulatory requirements and enforcement trends involving FARA, export controls, sanctions, and customs and tariff laws, and represents them in related government investigations.

Clients value Murad’s ability to provide strategic and empathetic guidance during their most challenging matters. Whether defending a physician in a criminal healthcare fraud investigation, advising a multinational manufacturer on cross-border compliance, or helping a foreign grant-funded organization respond to a government inquiry, Murad emphasizes practical solutions that account for legal, business, and reputational considerations.